$DDD 3 SEC Filings

Filed On	Filing
17 Jun 2024	Form 3: Wright Andrew William Banasick, SVP, GC & Secretary No securities owned
01 May 2024	Form 3: Roberson Keith, VP & Interim General Counsel Holds 29,120 shares of Common Stock
20 Dec 2023	Form 3: Currie Harriss T, President, Regenerative Med Holds 0 shares of Common Stock
19 Dec 2023	Form 3: Creech Jeffrey D, EVP & Chief Financial Officer Holds 0 shares of Common Stock
18 Oct 2023	Form 3: Wicklund Margaret E, Chief Accounting Officer Holds 0 shares of Common Stock
12 Dec 2022	Form 3: Zuiker Joseph R., EVP, Engineering & Operations Holds 0 shares of Common Stock
30 Aug 2022	Form 3: Turner Michael Lynn, EVP & Chief Financial Officer Holds 0 shares of Common Stock
23 May 2022	Form 3: Pensky Wayne C, Interim CFO Holds 1,000 shares of Common Stock
02 Dec 2021	Form 3: Drayton Claudia, Director Holds 0 shares of Common Stock
31 Aug 2021	Form 3: Nordstrom Phyllis B, EVP & CHRO Holds 0 shares of Common Stock
30 Jun 2021	Form 3: Leigh David K, EVP & CTO (Additive Mfg) Holds 630 shares of Common Stock
24 May 2021	Form 3: Crimmins Michael S, SVP, Chief Accounting Officer Holds 0 shares of Common Stock
12 Jan 2021	Form 3: Blank Jeff, EVP, Engineering and Prod Dev Holds 49,277 shares of Common Stock
02 Dec 2020	Form 3: Padmanabhan Vasant, Director Holds 0 shares of Common Stock
20 Nov 2020	Form 3: Grabenau Anthony, Principal Accounting Officer Holds 0 shares of Common Stock
06 Oct 2020	Form 3: Puthenveetil Reji, EVP, Industrial Solutions Holds 0 shares of Common Stock
15 Sep 2020	Form 3: Narula Jagtar, EVP & Chief Financial Officer Holds 0 shares of Common Stock
21 Jul 2020	Form 3: Ellis Menno, EVP, Healthcare Solutions Holds 105,071 shares of Common Stock
28 May 2020	Form 3: Pensky Wayne C, Interim CFO Holds 0 shares of Common Stock
28 May 2020	Form 3: Graves Jeffrey A, President and CEO Holds 0 shares of Common Stock

Comments